EE678 Time and Cost Savings from Adopting an Alternative Dosing Schedule with Pembrolizumab for Patients with Advanced Melanoma in Greece

Saved in:
Bibliographic Details
Published in:Value in health 2023-12, Vol.26 (12), p.S184
Main Authors: Draganigos, A., Yfantopoulos, N., Skroumpelos, A., Spanoudi, F., Karokis, A.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2023.09.943